Batavia Biosciences is your flexible partner to rely on at all stages of viral vector development. We aim to significantly contribute to ease human suffering from disease by improving the success rate in the translation of candidate medicines from discovery to the clinic. We offer our in depth know how in order to help our partners complete preclinical phases in viral vector development at higher speed, reduced cost and increased success. The company focuses on the early stages of product development including vector generation, upstream process development, purification development, product characterization and cGMP manufacturing. Headquartered in Leiden, The Netherlands, with a US-based facility in Woburn, Massachusetts, and offices in Hong Kong, Batavia Biosciences is privileged to have strong strategic partners worldwide.